Translate
Larimar Therapeutics Inc
About
Larimar Therapeutics Inc (NASDAQ:LRMR) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 19 2026
Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 4 2026
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
Feb 25 2026
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering
Feb 25 2026
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
Feb 24 2026
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
Financials
Revenue
$0
Market Cap
$497.6 M
EPS
-2.27